CI 10-K Annual Reports

The Cigna Group's 2024 Form 10-K highlights a year of significant operational activity and strategic repositioning. The company reported total revenues of $247.1 billion, a substantial increase driven primarily by growth in its Evernorth Health Services segment, particularly in Pharmacy Benefit Services. This segment saw a 32% increase in adjusted revenues, fueled by higher utilization and customer growth. However, the Cigna Healthcare segment experienced a decrease in pre-tax adjusted income from operations due to higher medical costs, which are impacting its medical care ratio. The company is in the process of divesting its Medicare Advantage and related businesses to HCSC, expected to close in early 2025, which will reshape its U.S. Healthcare segment. Financially, Cigna Group reported shareholders' net income of $3.4 billion, a decrease from the prior year, largely due to increased net investment losses, notably an impairment related to its VillageMD investment. Adjusted income from operations showed a modest 4% increase, reflecting the strength of Evernorth offsetting some of the pressures in Cigna Healthcare. The company continued its capital return strategy, repurchasing approximately $7 billion of its common stock in 2024 and maintaining its dividend payments, demonstrating a commitment to shareholder value despite the ongoing healthcare industry dynamics and specific business transformations.

The Cigna Group (CI) reported robust financial performance in its 2023 10-K filing, demonstrating growth across its key segments. The company's Evernorth Health Services segment showed significant revenue expansion, driven by strong performance in its pharmacy benefit services and specialty offerings. Cigna Healthcare also experienced revenue growth, largely due to an increase in medical customers and favorable premium rate adjustments. The company highlighted its strategic focus on innovation and digital capabilities to enhance customer experience and control costs. Significant strategic moves were announced, including the definitive agreement to sell its Medicare Advantage and related businesses to Health Care Service Corporation (HCSC) for $3.3 billion. This divestiture is expected to reshape the company's portfolio, allowing for a greater focus on its core Evernorth Health Services and evolving Cigna Healthcare offerings. The company also continued its commitment to returning capital to shareholders through share repurchases and dividends, signaling financial strength and confidence in its future prospects.

The Cigna Group's 2022 10-K filing reveals a robust financial performance, demonstrating resilience and strategic growth. The company reported a 24% increase in shareholders' net income, reaching $6.7 billion, driven by strong operational performance and the gain from the sale of international businesses. Adjusted income from operations saw a 4% increase to $7.3 billion, reflecting growth in both the Evernorth Health Services and Cigna Healthcare segments, supported by improved medical care ratios and cost management. Evernorth Health Services, the company's pharmacy and care solutions platform, experienced a 6% increase in adjusted revenues to $140.3 billion, fueled by strong specialty pharmacy performance and collaborative agreements. Cigna Healthcare, encompassing medical benefits, saw a 1% rise in adjusted revenues to $45 billion, benefiting from disciplined pricing and growth in specific market segments. The company also actively managed its capital, returning approximately $7.6 billion to shareholders through share repurchases and dividends, while maintaining a solid liquidity position. Strategic investments, including a significant commitment to VillageMD, highlight Cigna's focus on future growth and value-based care initiatives.

Cigna Group (CI) reported strong performance in its 2021 10-K filing, driven by its Evernorth health services segment which saw adjusted revenues increase by 14% year-over-year to $131.9 billion. The Cigna Healthcare segment also showed growth, with adjusted revenues up 9% to $44.7 billion, supported by an expanding customer base in Medicare Advantage and individual plans. The company completed significant strategic actions, including the acquisition of MDLIVE to enhance its virtual care capabilities and the agreement to sell its international life, accident, and supplemental benefits businesses to Chubb. These moves underscore Cigna's strategy to focus on its core health services offerings. Financially, the company demonstrated robust cash flow from operations, which supported significant capital deployment through share repurchases totaling $7.7 billion in 2021 and an increased quarterly dividend. While the company faced some headwinds, such as the ongoing impacts of COVID-19 on healthcare utilization and costs, it maintained effective cost management and operational efficiencies, leading to a 3% increase in adjusted income from operations. Investors can look to Cigna's continued focus on integrating digital capabilities, expanding its Evernorth platform, and disciplined capital allocation as key drivers for future value.

Cigna Corporation's 2020 Form 10-K highlights a year of strategic evolution and adaptation amidst the COVID-19 pandemic. The company reported a significant increase in Shareholders' Net Income, largely driven by the gain from the sale of its U.S. Group Disability and Life business. Adjusted Income from Operations also saw an increase, reflecting growth in the Evernorth segment due to expanded script volumes and customer growth, alongside improved results in International Markets. However, the Group Disability and Other segment experienced a downturn, primarily due to elevated life insurance claims related to COVID-19. The company demonstrated resilience by effectively managing operational impacts from the pandemic, including significant deferral of medical care followed by increased utilization for COVID-19 related services. Cigna continued its strategic focus on improving health, well-being, and peace of mind by offering affordable, predictable, and simple health care solutions. Key strategic initiatives included the launch of the Evernorth health services platform, aimed at integrating various health services capabilities to meet diverse client needs. The company also repurchased a substantial amount of its stock and initiated a quarterly cash dividend, signaling confidence in its financial position and commitment to returning capital to shareholders.

Cigna Group (CI) reported strong financial performance for the fiscal year ended December 31, 2019, driven by the acquisition of Express Scripts and growth in its Integrated Medical segment. Total revenues surged by 216% to $153.6 billion, largely due to the inclusion of Express Scripts' pharmacy benefit management and health services. Shareholders' net income increased by 94% to $5.1 billion, with diluted earnings per share rising to $13.44. The company's strategic focus remains on improving health, well-being, and peace of mind through its Go Deeper, Go Local, Go Beyond strategy. Key business segments include Health Services, Integrated Medical, International Markets, and Group Disability and Other. Cigna also announced its intent to sell its Group Disability and Life business in December 2019, a transaction expected to close in the third quarter of 2020. Looking ahead, Cigna is focused on continued integration of Express Scripts, driving innovation in health solutions, and managing costs effectively amidst a dynamic healthcare landscape. The company maintains a strong liquidity position and is actively managing its capital resources.

Cigna Group (CI) reported significant growth in its 2018 fiscal year, largely driven by the transformative acquisition of Express Scripts Holding Company, completed in December 2018. Total revenues increased by 16% to $48.7 billion, while shareholders' net income rose by 18% to $2.6 billion. The integration of Express Scripts significantly expanded Cigna's capabilities in health services, particularly in pharmacy benefit management, creating a more comprehensive health service organization. The company's strategy, "Go Deeper, Go Local, Go Beyond," leverages expanded capabilities to improve health outcomes and affordability. Key segments include Integrated Medical, Health Services, International Markets, and Group Disability and Other. The report highlights the strategic shift towards value-based care within the Integrated Medical segment and the focus on innovation in technology and data analytics across all operations. Despite the increased debt from the acquisition, Cigna remains focused on deleveraging and returning capital to shareholders through its share repurchase program.